Meeting Archive:
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation


Meeting Description:

Catheter ablation of atrial fibrillation is typically performed with uninterrupted anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant therapy. Uninterrupted anticoagulation with a non–vitamin K antagonist oral anticoagulant, such as dabigatran, may be safer; however, controlled data are lacking. We investigated the safety of uninterrupted dabigatran versus warfarin in patients undergoing ablation of atrial fibrillation.

View the abstract in the New England Journal of Medicine.  

Details
Date: Tue, Oct 17, 2017
Time: 02:30 PM EDT
Duration: 1 hour
Host(s): Elizabeth Goldstein, AC Forum
 Presenter Information
Edward P. Gerstenfeld, MD
 
Dr. Edward P. Gerstenfeld is chief of the Cardiac Electrophysiology and Arrhythmia Service at UCSF Medical Center. His expertise includes the treatment of arrhythmia, or irregular heartbeats, with catheter ablation, including endocardial and epicardial ablation, for atrial fibrillation, supraventricular tachycardias and ventricular tachycardia. 

Adam Cuker, MD
 
Adam Cuker is an assistant professor of medicine and pathology & laboratory medicine at the University of Pennsylvania. He is also an associate director for Clinical Research of the Penn-CHOP Blood center for Patient Care and Discovery and assistant director of the Penn Specialized Coagulation Laboratory. His area of focus is hemostasis/thrombosis and platelet immunology. He is also an AC Forum board member and co-chair of the Anticoagulation Forum webinar series.
 

Nathan Clark, PharmD, FCCP, BCPS
 

Dr. Clark manages The Clinical Pharmacy Anticoagulation and Anemia Service at Kaiser Permanente Colorado, one of the largest centralized anticoagulation services in North America. Dr. Clark is board certified in pharmacotherapy and a fellow in the American College of Clinical Pharmacy. He is also a clinical instructor with the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Clark has authored or co-authored publications in Annals of Internal Medicine, JAMA Internal Medicine, Journal of Thrombosis and Thrombolysis, and Blood.